Cargando…

Iguratimod alleviates tubulo-interstitial injury in mice with lupus

INTRODUCTION: Tubulo-interstitial injury is a poor prognostic factor for lupus nephritis (LN). Here, we tested whether iguratimod could inhibit tubulo-interstitial injury in LN. METHODS: MRL/lpr mice, an animal model of lupus, were treated with iguratimod or vehicle solution. Pathological changes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Leixi, Xu, Jiajun, Lu, Wentian, Fu, Jinxiang, Liu, Zhichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004506/ https://www.ncbi.nlm.nih.gov/pubmed/35387545 http://dx.doi.org/10.1080/0886022X.2022.2058962

Ejemplares similares

Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2021)

Allergic Skin Rash Caused by Iguratimod: A Report of Two Cases
por: Lu, Wentian, et al.
Publicado: (2022)

The Clinical Characteristics of Leukopenia in Patients with Systemic Lupus Erythematosus of Han Ethnicity in China: A Cross-Sectional Study
por: Lu, Wentian, et al.
Publicado: (2021)

Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort
por: Zhang, Lin, et al.
Publicado: (2023)

Diagnostic accuracy of the European League against rheumatism/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis
por: Lu, Wentian, et al.
Publicado: (2022)

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis
por: Weng, Chenghua, et al.
Publicado: (2021)

Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy
por: Grande, María T, et al.
Publicado: (2010)

Utility of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study
por: Lu, Wentian, et al.
Publicado: (2022)

Chemokine (C-C Motif) Ligand 8 and Tubulo-Interstitial Injury in Chronic Kidney Disease
por: Lee, Jangwook, et al.
Publicado: (2022)

Acute tubulo-interstitial nephritis leading to acute renal failure following multiple hornet stings
por: Sharma, Aman, et al.
Publicado: (2006)

Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
por: Kang, Yuening, et al.
Publicado: (2020)

A case report of zinc phosphide poisoning: complicated by acute renal failure and tubulo interstitial nephritis
por: Yogendranathan, Nilukshana, et al.
Publicado: (2017)

An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration
por: Spapen, Jerrold, et al.
Publicado: (2015)

Long-term Treatment Outcome of Tubulo-interstitial Nephritis and Uveitis Syndrome Associated Panuveitis with Steroid and Mycophenolate Mofetil
por: Leung, Kai Ching Peter, et al.
Publicado: (2020)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
por: Weng, Chenghua, et al.
Publicado: (2023)

Anti-inflammatory effects of saxagliptin and vildagliptin against doxorubicin-induced nephrotoxicity in rats: attenuation of NLRP3 inflammasome up-regulation and tubulo-interstitial injury
por: Mostafa, Rasha Ezzat, et al.
Publicado: (2021)

Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
por: Li, Jiangtao, et al.
Publicado: (2013)

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia
por: Wang, Shuhua, et al.
Publicado: (2023)

Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice
por: Yan, Qingran, et al.
Publicado: (2014)

Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis
por: Yang, Ru, et al.
Publicado: (2016)

Correction: Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis
por: Yang, Ru, et al.
Publicado: (2017)

Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia
por: Bolar, Nikhita Ajit, et al.
Publicado: (2016)

Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
por: Lin, Jin, et al.
Publicado: (2019)

A Rare Case of Primary Sjogren’s Syndrome Coexisting With Gilbert Syndrome
por: Zhang, Lin, et al.
Publicado: (2023)

Tubulo-villous adenoma of the appendix: A case report and review of the literature
por: Evola, Giuseppe, et al.
Publicado: (2019)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2017)

Axl Tyrosine Kinase Protects against Tubulo-Interstitial Apoptosis and Progression of Renal Failure in a Murine Model of Chronic Kidney Disease and Hyperphosphataemia
por: Hyde, Gareth D., et al.
Publicado: (2014)

Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease
por: Izzi, Claudia, et al.
Publicado: (2020)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway
por: Liu, Zhiqin, et al.
Publicado: (2016)

Iguratimod Alleviates Myocardial Ischemia/Reperfusion Injury Through Inhibiting Inflammatory Response Induced by Cardiac Fibroblast Pyroptosis via COX2/NLRP3 Signaling Pathway
por: Zhang, Mian, et al.
Publicado: (2021)

Role of SNX16 in the Dynamics of Tubulo-Cisternal Membrane Domains of Late Endosomes
por: Brankatschk, Ben, et al.
Publicado: (2011)

Le carcinome tubulo-mucineux et fusiforme: une tumeur rénale rare
por: Ziouani, Oussama, et al.
Publicado: (2017)

Effects of iguratimod on inflammatory factors and apoptosis of submandibular gland epithelial cells in NOD mice
por: Wang, Shuying, et al.
Publicado: (2023)

Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature
por: Li, Xiao-li, et al.
Publicado: (2018)

Hypertrophic osteoarthropathy
por: Wang, Gang, et al.
Publicado: (2023)

Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer
por: Yan, Qingran, et al.
Publicado: (2023)

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h0couu5i6nss2qiost5e96h0d6